Post-bronchodilator spirometry reference values in adults and implications for disease management

被引:136
作者
Johannessen, Ane [1 ]
Lehmann, Sverre
Omenaas, Ernst R.
Eide, Geir Egil
Bakke, Per S.
Gulsvik, Amund
机构
[1] Haukeland Hosp, Ctr Clin Res, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Thorac Med, N-5021 Bergen, Norway
[3] Univ Bergen, Inst Med, Bergen, Norway
[4] Univ Bergen, Sect Epidemiol & Med Stat, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway
关键词
COPD; quantile regression; reference values; reversibility test; spirometry;
D O I
10.1164/rccm.200601-023OC
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Rationale: International guidelines promote the use of post-bronchodilator spirometry values in the definition and severity classification of chronic obstructive pulmonary disease. However, post-bronchodilator reference values have not yet been developed. Objectives: To derive reference values for post-bronchodilator forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC, and to compare these reference values with locally derived and existing pre-bronchodilator reference values. Methods: Based on a random sample of a general adult population, 2,235 subjects (70% of invited subjects) performed spirometry with reversibility testing. A reference population of healthy never-smokers constituted 23% of the study population (n = 515). Reference values for median and lower-limit-of-normal pre- and post-bronchodilator lung function and bronchodilator response were modeled using quantile regression analyses. Main Results: The reference population had equal proportions of men and women in the age range 26-82 yr. Both FEV1 and FVC decreased with age and increased with height. FEV1/FVC decreased with age, although this trend was not statistically significant for men after bronchodilatation. Linear models gave the best overall fit. Lower-limit-of-normal post-bronchodilator FEV1/FVC exceeded 0.7 for both sexes. Post-bronchodilator prediction equations gave higher predicted FEV1 and FEV1/FVC than both locally derived and existing pre-bronchodilator equations. The bronchodilator response decreased with age. Conclusions: The present study is the first to develop reference values for post-bronchodilator lung function. Post-bronchodilator prediction equations can facilitate better management of patients with chronic obstructive pulmonary disease by avoiding falsely high FEV1% predicted with a subsequent underestimation of disease severity.
引用
收藏
页码:1316 / 1325
页数:10
相关论文
共 37 条
[1]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[2]
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107
[3]
Bronchodilator response in the lung health study over 11 yrs [J].
Anthonisen, NR ;
Lindgren, PG ;
Tashkin, DP ;
Kanner, RE ;
Scanlon, PD ;
Connett, JE .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (01) :45-51
[4]
PREVALENCE OF OBSTRUCTIVE LUNG-DISEASE IN A GENERAL-POPULATION - RELATION TO OCCUPATIONAL TITLE AND EXPOSURE TO SOME AIRBORNE AGENTS [J].
BAKKE, PS ;
BASTE, V ;
HANOA, R ;
GULSVIK, A .
THORAX, 1991, 46 (12) :863-870
[5]
Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[6]
Lung function in healthy never smoking adults: Reference values and lower limits of normal of a Swiss population [J].
Brandli, O ;
Schindler, C ;
Kunzli, N ;
Keller, R ;
Perruchoud, AP ;
Leuenberger, P ;
AckermannLiebrich, U ;
Alean, P ;
Blaser, K ;
Bolognini, G ;
Bongard, JP ;
Braun, P ;
Bron, C ;
Brutsche, M ;
Defila, C ;
Domenighetti, G ;
Elasser, S ;
Grize, L ;
Guldimann, P ;
Hufschmid, P ;
Karrer, W ;
KellerWossidlo, H ;
Luthy, JC ;
Martin, BW ;
Medici, T ;
Monn, C ;
Peeters, AG ;
Radaelli, A ;
Schwartz, J ;
Solari, G ;
Schoni, M ;
Tschopp, JM ;
Villiger, B ;
Wuthrich, B ;
Zellweger, JP ;
Zemp, E .
THORAX, 1996, 51 (03) :277-283
[7]
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[8]
Albuterol via Turbuhaler versus albuterol via pressurized metered-dose inhaler in asthma [J].
Chapman, KR ;
Friberg, K ;
Balter, MS ;
Hyland, RH ;
Alexander, M ;
Abboud, RT ;
Peters, S ;
Jennings, BH .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 78 (01) :59-63
[9]
CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659
[10]
CLINICAL INTERPRETATION OF AIRWAY RESPONSE TO A BRONCHODILATOR - EPIDEMIOLOGIC CONSIDERATIONS [J].
DALES, RE ;
SPITZER, WO ;
TOUSIGNANT, P ;
SCHECHTER, M ;
SUISSA, S .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :317-320